FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

BLUESTARCO Share Price Target

Blue Star Ltd.
NSE: BLUESTARCO | BSE: 500067 | ISIN: INE472A01039 | Sector: Consumer Durables

BLUESTARCO Rating

4.6/5 (12 Ratings)
BLUESTARCO Share Price *
845 -1 (-0.12%)
* (quote may be delayed)

12 BLUESTARCO share price target reports by brokerages below. See what is analyst's view on BLUESTARCO share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.


You can also find BLUESTARCO share price target tomorrow or next week from BLUESTARCO discussion forum.

BLUESTARCO Share Price Forecast - Consensus
No. of reports in last year
12
No. of analysts
6
Average Consensus Forecast
872.75
Consensus Potential
2.03%

BLUESTARCO Share Price Target - Broker Reports - 2020

31-Jan-20
Price @ Call: 830.64
Target: 970
BUY

3-Feb-20
Price @ Call: 834.85
Target: 922
BUY
With expected normal onset of summer providing good demand for cooling products and the government announced infra spend of Rs105tn in next 5 years augers well for the company to get orders with improvement in margins. Based on these factors, we estimate a CAGR earnings growth of 21% over FY19-22E and maintain our BUY with a target price of Rs 922 (P/E 24x FY22E)
... Read more

BLUESTARCO Share Price Target - Broker Reports - 2019

15-Nov-19
Price @ Call: 809.3
Target: 970
BUY
Blue Star (BLSTR) reported consolidated revenue of Rs12.5bn for 2QFY20, up 21% YoY, above our/consensus estimate of Rs11bn each. Unitary Products segment’s revenue grew by 10% YoY to Rs3.8bn in a non-seasonal quarter, while demand was driven by Tier 3/4/5 towns. EMPS segment’s revenue grew by 24% YoY to Rs7.8bn on execution of a healthy order book. Order book grew by 32% YoY and 3% QoQ to Rs29.4bn as on 1HFY20. Unitary Products’ EBIT margin grew by 80bps YoY to 3.2%, while EMPS segment’s margin fell 140bps YoY at 5.7%, on a high base, but up 30bps QoQ. Consolidated EBITDA margin rose by 30bps YoY to 5.9%, exactly in- line with our/consensus estimate. The company has not shifted to the lower tax regime as it is yet to avail Rs670mn worth of MAT credit. Lower interest costs and higher other income aided bottomline, with the PAT growing by 94% YoY to Rs379mn, above our/consensus estimates of Rs301mn/Rs320mn. We have marginally tweaked our estimates and retained Buy rating on BLSTR with a SOTP-based target price of Rs970 (Rs965 earlier). On September 2021E earnings, we assign a P/E of 35x to Unitary Product segment and 15x to the project business.
... Read more

15-Nov-19
Price @ Call: 809.3
Target: 980
BUY
We estimate Blue Star to report top-line CAGR of ~13% to`6,651cr over FY2019-21E on the back of healthy demand growth in Air Conditioning and Unitary Products division. On the bottom-line front, we estimate ~20% CAGR to`269cr owing to improvement in volumes and better operating margins. We maintain our Buy recommendation on Blue Star with a Target Price of Rs980.
... Read more

15-Nov-19
Price @ Call: 809.3
Target: 941
BUY
Looking ahead, we expect BLSTR’s revenue and earnings to clock 12% and 21% CAGR, respectively through FY19-21E. At CMP, the stock trades at 34.2x FY20E and 28.4x of FY21E earnings. We are positive on BLSTR on the back of improving margin profile, healthy balance sheet, improving return ratios and improving market share. We maintain our BUY recommendation on the stock with a revised Target Price of Rs941, valuing it at 33x of FY21 earnings.
... Read more

19-Aug-19
Price @ Call: 698.05
Target: 833
BUY
We continue to maintain our estimates and expect a CAGR earning growth of 20% over FY19-21E on the back improvement in sales of cooling products and realignment of order execution by the company in the EMPS segment enabled by better working capital management. We are positive on the back of improving margin profile, return ratios and increasing market share. We maintain our BUY with a target price of Rs 833(P/E 25x FY21E)
... Read more

17-Aug-19
Price @ Call: 708.94
Target: 747
BUY
In terms of valuation, the stock is trading at 34.4x and 25.9x FY20E and FY21E earnings. In view of the earnings revision in FY21E, our price target stands revised to Rs 747 (Rs 713 earlier). In view of positive outlook on Room ACbusiness but offset by premium valuations, we recommend “ADD” as upside ismodest.
... Read more

4-Jul-19
Price @ Call: 764.4
Target: 899
BUY
The company has good distribution outreach both domestic and international, favourable market position and product-mix (both in UCP and EMPS), good return ratios, consistent strong cash flows and a sustainable leverage position enabling to provide good RoE and EPS growth prospects over the long run. Hence, we initiate coverage with a BUY rating and a target price of `899 (P/E 27x FY21E)
... Read more

3-May-19
Price @ Call: 696.33
Target: 829
BUY
Looking ahead, we expect BLSTR’s revenue and earnings to clock 13% and 14% CAGR, respectively through FY19-21E. At CMP, the stock trades at 32.3x FY20E and 27.5x of FY21E earnings. We are positive on BLSTR on the back of improving margins, healthy balance sheet, low debt, improving return ratios and improving market share. We maintain our BUY recommendation on the stock with an upwardly revised Target Price of Rs829 (from Rs806 earlier), valuing the stock at 33x FY21 earnings.
... Read more

6-May-19
Price @ Call: 697
Target: 867
BUY
We forecast Blue Star to report top-line CAGR of ~13% to `6,680cr over FY2019-21E on the back of healthy demand growth in Air Conditioning and Unitary Products division. On the bottom-line front, we estimate ~14% CAGR to Rs 246cr owing to improvement in volumes and better operating margins. We maintain our Buy recommendation on Blue Star with a Target Price of Rs 867.
... Read more

9-Apr-19
Price @ Call: 689.96
Target: 700
HOLD

2-Apr-19
Price @ Call: 707.69
Target: 815
BUY
We expect BLSTR to post 14% net revenue CAGR over FY18- FY21E. Along with operating leverage benefit (with rising scale), in-house manufacturing of room ACs, turnaround in water purifier business and improving revenue mix of EMPS segment (higher share of product and service business) will lead to improvement in the margin profile. We expect EBITDA margin to improve 190bps over FY18-FY21E, leading to a 30% adjusted earnings CAGR over FY18-FY21E. Over the next five years, BLSTR’s management has ambitious plan of growing revenues by 20% CAGR and profitability by 25% CAGR. We initiate coverage on BLSTR with a Buy rating and a target price of Rs815 based on SOTP method.
... Read more

14-Feb-19
Price @ Call: 588.78
Target: 867
BUY
We forecast Blue Star to report top-line CAGR of ~12% to Rs 5,871cr over FY2018-20E on the back of healthy demand growth in Air Conditioning and Unitary Products division. On the bottom-line front, we estimate ~17% CAGR to Rs 198cr owing to improvement in volumes and better operating margins. We maintain our Buy recommendation on Blue Star with a Target Price of Rs 867.
... Read more

8-Feb-19
Price @ Call: 590
Target: 806
BUY

7-Feb-19
Price @ Call: 584.25
Target: 620
NEUTRAL

7-Feb-19
Price @ Call: 584.25
Target: 620
ADD

BLUESTARCO Share Price Target - Broker Reports - 2018

1-Nov-18
Price @ Call: 574
Target: 655
BUY

10-Aug-18
Price @ Call: 703
Target: 743
ACCUMULATE

18-Jul-18
Price @ Call: 659.05
Target: 701
ACCUMULATE

1-Jun-18
Price @ Call: 702.95
Target: 790
NEUTRAL

16-May-18
Price @ Call: 755.9
Target: 860
NEUTRAL

6-Apr-18
Price @ Call: 796.78
Target: 867
BUY

7-Feb-18
Price @ Call: 738.45
Target: 780
NEUTRAL

BLUESTARCO Share Price Target - Broker Reports - 2017

9-Oct-17
Price @ Call: 798.2
Target: 850
BUY

12-May-17
Price @ Call: 676
Target: 750
ACCUMULATE

14-Jun-17
Price @ Call: 646
Target: 684
ACCUMULATE

12-May-17
Price @ Call: 665
Target: 763
ACCUMULATE

BLUESTARCO Share Price Target - Broker Reports - 2016

15-Nov-16
Price @ Call: 465
Target: 580
BUY

8-Jun-16
Price @ Call: 433.82
Target: 495
BUY

  • BLUESTARCO - Share Price Target Potential

    keyboard_arrow_down
    BrokerageTargetPotential
    Nirmal Bang97012.78%
    Way2Wealth9228.24%
    Angel Broking98013.67%
    Reliance Securities94110.10%
    Kotak Securities747-13.25%
  • BLUESTARCO Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3874.12
    Upside Target 2862.53
    Upside Target 1853.17
    Pivot841.58
    Downside Target 1832.22
    Downside Target 2820.63
    Downside Target 3811.27
  • BLUESTARCO Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3914.1
    Upside Target 2889
    Upside Target 1867.25
    Pivot842.15
    Downside Target 1820.4
    Downside Target 2795.3
    Downside Target 3773.55
  • BLUESTARCO Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3977.08
    Upside Target 2932.32
    Upside Target 1886.03
    Pivot841.27
    Downside Target 1794.98
    Downside Target 2750.22
    Downside Target 3703.93
  • BLUESTARCO Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3862.53
    Upside Target 2854.53
    Upside Target 1849.59
    Pivot841.58
    Downside Target 1833.58
    Downside Target 2828.64
    Downside Target 3820.63
  • BLUESTARCO Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3889
    Upside Target 2871.1
    Upside Target 1860.05
    Pivot842.15
    Downside Target 1824.25
    Downside Target 2813.2
    Downside Target 3795.3
  • BLUESTARCO Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3932.32
    Upside Target 2897.54
    Upside Target 1876.05
    Pivot841.27
    Downside Target 1806.49
    Downside Target 2785
    Downside Target 3750.22
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.